Back to TMO
TRUIST FINANCIAL CORP TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
22
Latest value
$42.1M
Q3 2026
Peak value
$42.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.3M |
| Q3 2025 | $2K |
| Q3 2025 | $1.6M |
| Q3 2025 | $26.6M |
| Q3 2025 | $28.8M |
| Q4 2025 | $1.6M |
| Q4 2025 | $1.7M |
| Q4 2025 | $31.8M |
| Q4 2025 | $32.7M |
| Q1 2026 | $2.8M |
| Q1 2026 | $1.3M |
| Q1 2026 | $25.8M |
| Q1 2026 | $28.2M |
| Q2 2026 | $5.2M |
| Q2 2026 | $4.4M |
| Q2 2026 | $1.3M |
| Q2 2026 | $23.5M |
| Q2 2026 | $29.3M |
| Q3 2026 | $5.9M |
| Q3 2026 | $1.4M |
| Q3 2026 | $30.4M |
| Q3 2026 | $42.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $42.1M | 62.4K | — | — |
| Q3 2026 | $30.4M | 45.0K | — | — |
| Q3 2026 | $1.4M | 2.0K | — | — |
| Q3 2026 | $5.9M | 110.3K | — | — |
| Q2 2026 | $29.3M | 58.5K | — | — |
| Q2 2026 | $23.5M | 46.9K | — | — |
| Q2 2026 | $1.3M | 2.7K | — | — |
| Q2 2026 | $4.4M | 82.4K | — | — |
| Q2 2026 | $5.2M | 140.2K | — | — |
| Q1 2026 | $28.2M | 57.4K | — | — |
| Q1 2026 | $25.8M | 52.4K | — | — |
| Q1 2026 | $1.3M | 2.7K | — | — |
| Q1 2026 | $2.8M | 54.5K | — | — |
| Q4 2025 | $32.7M | 56.4K | — | — |
| Q4 2025 | $31.8M | 54.9K | — | — |
| Q4 2025 | $1.7M | 2.9K | — | — |
| Q4 2025 | $1.6M | 31.3K | — | — |
| Q3 2025 | $28.8M | 59.4K | — | — |
| Q3 2025 | $26.6M | 54.8K | — | — |
| Q3 2025 | $1.6M | 3.3K | — | — |
| Q3 2025 | $2K | 33 | — | — |
| Q3 2025 | $1.3M | 25.7K | — | — |
Other funds holding TMO
$17.6B
$15.8B
$14.7B
$10.1B
$9.6B
$9.6B